Axim Biotechnologies Inc (OTCMKTS: AXIM) is at the helm of affairs. The group recently announced that it had included Dr. Laura Periman in its Medical Advisory Board.
Dr. Periman is a specialist in ocular surface disease and dry eye disease (DED)
With three decades’ experience in medicine, Dr. Periman has spent the last 20 years in clinical practice, besides specializing in ocular surface disease and dry eye disease (DED). At present, she is appointed as Founder and Director of Dry Eye Services and Clinical Research of the Periman Eye Institute, based out of Seattle. In the past, she has worked as principal investigator in ophthalmic clinical research, primarily specializing in treating DED, IPL procedures, and radiofrequency. In addition, Dr. Periman is academically inclined as she is an international lecturer. To her credit, she has reviewed and edited research papers for several medical journals. Furthermore, she has served as a consultant for various ophthalmic pharmaceutical and medical device companies on the corporate front.
With the new addition, Axim Biotechnologies Inc is targeting growth
The Chief Executive Officer of Axim Biotechnologies Inc, John W. Huemoeller II, went on record and stated that the company is targeting to grow from strength to strength with the new addition. Huemoeller II expressed joy in having a world-class DED expert included in the group’s Medical Advisory Board. He stated that Dr. Periman dons many hats as she has a sea of experience as a clinician, investigator, consultant, researcher, editor, and reviewer. The CEO of the group added that the wealth of knowledge that Dr. Periman brings with her could be used to commercialize the company’s ophthalmic diagnostic lab tests besides strengthening the group’s ophthalmic division.
The focus is on treating dry eyes disease as prevalence is high
If numbers are to be believed, the prevalence of dry eyes disease is high, both in the U.S. and across the world. According to the recent data, around 26 million people suffer from this condition in the U.S. alone, and another 300 million individuals are victims of this disease across the globe. Thus, it calls for immediate attention. The fact that this disease affects the young and old, male and female, is a cause of worry.
Curaleaf Holdings Inc (OTCMKTS: CURLF) Is Opening a Dispensary at State College
Post Views: 266 Curaleaf Holdings Inc (OTCMKTS: CURLF) is opening a State College Dispensary at 1248 A Atherton St, State...
Puration Inc (OTCMKTS: PURA) Is About to Make Its First Collaboration in the Asia Pacific
Post Views: 484 Puration Inc (OTCMKTS: PURA) is about to strike a deal for its first collaboration in the Asia...
Harborside Inc (OTCMKTS: HBORF) Will Convert Multiple Voting Shares Into Subordinate Voting Shares
Post Views: 2,863 Harborside Inc (OTCMKTS: HBORF) has announced that it will convert its outstanding and issued multiple voting shares...
Trulieve Cannabis Corp (OTCMKTS: TCNNF) Announces Partnership With Khalifa Kush
Post Views: 495 Trulieve Cannabis Corp (OTCMKTS: TCNNF) Khalifa Kush has announced an exclusive partnership. Khalifa Kush is a brand...
Indiva Ltd (OTCMKTS: NDVAF) Launches Jewel Cannabis Tarts
Post Views: 357 Indiva Ltd (OTCMKTS: NDVAF) recently launched Jewel Cannabis Tarts, its latest products into the cannabis Industry. The...
Neptune Wellness Solutions Inc’s (NASDAQ: NEPT) Subsidiary, Sprout Organics, Executes a Partnership With Cocomelon for the Distribution of Organic Produce
Post Views: 542 Sprout Organics, a subsidiary of Neptune Wellness Solutions Inc (NASDAQ; NEPT), recently announced the execution of its...